Syndicated BioPharma Registry Data and Consulting Services


Add photos to showcase CorEvitas’s culture


Add CorEvitas’s values

Insider experiences

Share your experience of working at CorEvitas

Raymond Hill
CEO & Chairman
DB Kartik
President & COO
Leslie R. Harrold
Chief Scientific Officer
Delfi Nieto
Chief HR Officer
Abbe Steel
Chief Growth Officer
Jeffrey Greenberg
Chief Medical Officer
Jilani Gulam
President, Specialty EMR Data
Jennifer Kelly
President, Patient Experience
Jessica Eisenhaure
SVP & General Counsel

Add your teams to show how people work together at CorEvitas

Add jobs to your org chart to show candidates who they’ll work with

Team announcement

Michael Weintraub Joins CorEvitas Board of Directors

Michael Weintraub Joins CorEvitas Board of Directors

WALTHAM, Mass. and LONDON, March 23, 2021 /PRNewswire/ -- Michael Weintraub, Co-Founder and Managing Partner of Ardan Equity ("Ardan"), has joined the CorEvitas board of directors. CorEvitas [kohr-eh'-vi-tahs], formerly known as Corrona, LLC, is a built-for-purpose provider of gold-standard real-world evidence, advancing patient care by generating high quality curated data on newly approved therapies. Noted Michael Weintraub, "We are excited to partner with CorEvitas and Audax Private Equity in this next chapter. CoreEvitas is a pioneer and leader in real world evidence, with a twenty-year track record of innovation and growth. As a de-facto standard for pharmacovigilance across a rapidly growing therapeutic portfolio with a marquee global customer footprint and a best-in-class data asset, CorEvitas is uniquely poised to leverage its platform and solutions moving forward." Mr. Weintraub is a managing partner of Ardan Equity, the first private equity firm to focus exclusively on healthcare and life sciences software and data. He is also the Founding Chair of Phreesia. Throughout his career, Mr. Weintraub has been a pioneer and leader in the field of healthcare and life sciences data and analytics. He was the Co-Founder and CEO of Humedica (acquired by Optum), and the CEO of PharMetrics (acquired by IMS/ IQVIA). Mr. Weintraub serves in multiple capacities as investor, director, and advisor to a portfolio of market leading companies in digital health, both in the U.S. and globally, and is among the industry's foremost experts in data-based SaaS digital health business models. Mr. Weintraub serves as an Entrepreneur in Residence at Harvard Business School, where he is also an alumnus. "We see a future of innovation providing a deeper, more complete picture of a patient, where real-world evidence is central to ensuring their health and safety. We are excited to have Michael leverage his significant and relevant experience to help shape the future or our organization," said Raymond Hill, CEO and Chairman of CorEvitas. Joe Rogers, Managing Director at Audax added, "We are very excited to welcome Michael to the board of directors at CorEvitas. We believe his deep industry knowledge and experience will be instrumental to the future growth of the company." CorEvitas is building a leading position in real world evidence across registries, patient experience, electronic medical records, claims and data analytics, as well as biosamples. The organization is committed to ensuring the best therapies and care are delivered to the patients that need them the most by systematically collecting high quality data and applying rigorous analytic methods.

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.